Dyne Therapeutics Inc DELIVER Clinical Update Transcript - Thomson StreetEvents

Dyne Therapeutics Inc DELIVER Clinical Update Transcript

Dyne Therapeutics Inc DELIVER Clinical Update Transcript - Thomson StreetEvents
Dyne Therapeutics Inc DELIVER Clinical Update Transcript
Published Sep 03, 2024
13 pages (8500 words) — Published Sep 03, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of DYN.OQ corporate analyst meeting

  
Brief Excerpt:

...Good morning, everyone. I'm Amy Reilly, Senior Vice President, Head of Corporate Communications and Investor Relations at Dyne. Thank you, for joining us for Dyne virtual events review compelling new clinical data from our Phase 1/2 DELIVER trial DYNE-215 and people with duchenne muscular dystrophy, or amenable to exon 51 skipping. Before we get started, I'd like to remind everyone that we will be making forward-looking statements today that are subject to the safe harbor protections provided under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our most recent Form 10-Q. These statements represent Dyne's views as of today's date, and we disclaim any obligation to update these statements, except as required by law. For toady's program, John Cox, President and CEO, will offer some brief remarks on the DELIVER trial...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Dyne Therapeutics Inc
Ticker
DYN.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Dyne Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2025-09-08 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 8-Sep-25 1:15pm GMT

Dyne Therapeutics Inc Update on DYNE-101 for Myotonic Dystrophy Type 1 Conference Call Transcript – 2025-06-17 – US$ 54.00 – Edited Transcript of DYN.OQ conference call or presentation 17-Jun-25 12:00pm GMT

Dyne Therapeutics Inc at JPMorgan Healthcare Conference Transcript – 2025-01-15 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 15-Jan-25 6:30pm GMT

Dyne Therapeutics Inc ACHIEVE Clinical Update Transcript – 2025-01-10 – US$ 54.00 – Edited Transcript of DYN.OQ corporate analyst meeting</ 10-Jan-25 1:00pm GMT

Dyne Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2024-09-05 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 5-Sep-24 8:05pm GMT

Dyne Therapeutics Inc at JPMorgan Healthcare Conference Transcript – 2024-01-09 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 9-Jan-24 10:15pm GMT

Dyne Therapeutics Inc at Jefferies CNS & Neuro Summit Transcript – 2023-10-12 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 12-Oct-23 1:30pm GMT

Dyne Therapeutics Inc at Chardan Genetic Medicines Conference Transcript – 2023-10-03 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 3-Oct-23 3:00pm GMT

Dyne Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-11 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 11-Sep-23 8:15pm GMT

Dyne Therapeutics Inc at Jefferies Healthcare Conference Transcript – 2023-06-08 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 8-Jun-23 6:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Dyne Therapeutics Inc DELIVER Clinical Update Transcript" Sep 03, 2024. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Dyne-Therapeutics-Inc-DELIVER-Clinical-Update-T16116560>
  
APA:
Thomson StreetEvents. (2024). Dyne Therapeutics Inc DELIVER Clinical Update Transcript Sep 03, 2024. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Dyne-Therapeutics-Inc-DELIVER-Clinical-Update-T16116560>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.